Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II

Rationale: The Scleroderma Lung Study II (SLS II) demonstrated significant improvements in pulmonary function and dyspnea at 24 months compared with baseline when patients with symptomatic scleroderma–related interstitial lung disease (SSc-ILD) were treated with either cyclophosphamide for 1 year (f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Am Thorac Soc
Main Authors: Goldin, Jonathan G., Kim, Grace Hyun J., Tseng, Chi-Hong, Volkmann, Elizabeth, Furst, Daniel, Clements, Philip, Brown, Matt, Roth, Michael, Khanna, Dinesh, Tashkin, Donald P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322015/
https://ncbi.nlm.nih.gov/pubmed/30265153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201802-079OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados